Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim
{"title":"使用直接作用抗病毒药物获得持续病毒学应答的 HCV 引起的肝硬化补偿患者肝细胞癌的临床流行病学研究。","authors":"Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim","doi":"10.21608/aeji.2024.264655.1352","DOIUrl":null,"url":null,"abstract":"HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.","PeriodicalId":504099,"journal":{"name":"Afro-Egyptian Journal of Infectious and Endemic Diseases","volume":"327 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Drugs.\",\"authors\":\"Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim\",\"doi\":\"10.21608/aeji.2024.264655.1352\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.\",\"PeriodicalId\":504099,\"journal\":{\"name\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"volume\":\"327 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/aeji.2024.264655.1352\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Afro-Egyptian Journal of Infectious and Endemic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/aeji.2024.264655.1352","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Drugs.
HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.